GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Gross Margin %

argenx SE (argenx SE) Gross Margin % : 90.30% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. argenx SE's Gross Profit for the three months ended in Dec. 2023 was $367 Mil. argenx SE's Revenue for the three months ended in Dec. 2023 was $407 Mil. Therefore, argenx SE's Gross Margin % for the quarter that ended in Dec. 2023 was 90.30%.


The historical rank and industry rank for argenx SE's Gross Margin % or its related term are showing as below:

ARGX' s Gross Margin % Range Over the Past 10 Years
Min: 90.39   Med: 91.61   Max: 92.83
Current: 90.39


During the past 13 years, the highest Gross Margin % of argenx SE was 92.83%. The lowest was 90.39%. And the median was 91.61%.

ARGX's Gross Margin % is ranked better than
86.26% of 735 companies
in the Biotechnology industry
Industry Median: 59.4 vs ARGX: 90.39

argenx SE had a gross margin of 90.30% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for argenx SE was 0.00% per year.


argenx SE Gross Margin % Historical Data

The historical data trend for argenx SE's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Gross Margin % Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 92.83 90.39

argenx SE Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.66 91.63 91.12 89.08 90.30

Competitive Comparison of argenx SE's Gross Margin %

For the Biotechnology subindustry, argenx SE's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Gross Margin % distribution charts can be found below:

* The bar in red indicates where argenx SE's Gross Margin % falls into.



argenx SE Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

argenx SE's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1108.5 / 1226.316
=(Revenue - Cost of Goods Sold) / Revenue
=(1226.316 - 117.835) / 1226.316
=90.39 %

argenx SE's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=367.4 / 406.837
=(Revenue - Cost of Goods Sold) / Revenue
=(406.837 - 39.477) / 406.837
=90.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


argenx SE  (NAS:ARGX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

argenx SE had a gross margin of 90.30% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


argenx SE Gross Margin % Related Terms

Thank you for viewing the detailed overview of argenx SE's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (argenx SE) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.